FindTrial
Sign In

CTCs detection in precise diagnosis and personalized treatment of epithelial ovarian cancer - A prospective randomized controlled study

CTCs detection in precise diagnosis and personalized treatment of epithelial ovarian cancer - A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009601
Enrollment
Unknown
Registered
2016-10-25
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Gold Standard:
Index test:

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and more; No cognitive dysfunction; 2. Operation completely at the first time; 3. Pathological diagnosis is epithelial ovarian cancer; 4. Same surgeon group; 5. Surgical pathological stage; 6. No drug therapy before operation.

Exclusion criteria

Exclusion criteria: 1. Pathological diagnosis is non-epithelial ovarian cancer; 2. Second operation; 3. Second tumor is confirmed in therapy; 4. ECOG scored or Laboratory test indicate unfit to endure chemotherpy; 5. Combination of disease is not suitable for surgery and/or chemotherapy; 6. Receive chemotherapy or radiotherapy experimental hormone treatment biological agents treatment in the past.

Design outcomes

Primary

MeasureTime frame
CTCs;—

Countries

China

Contacts

Public ContactYu Wang

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

renjiwangyu@126.com+86 18918358318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026